Literature DB >> 17765184

Paying for modern cancer care--a global perspective.

Michael Rawlins1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17765184     DOI： 10.1016/S1470-2045(07)70250-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

1.  International variability in the reimbursement of cancer drugs by publically funded drug programs.

Authors:  P K Cheema; S Gavura; M Migus; B Godman; L Yeung; M E Trudeau
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

2.  A Time-Trend Economic Analysis of Cancer Drug Trials.

Authors:  Sonya Cressman; George P Browman; Jeffrey S Hoch; Laurel Kovacic; Stuart J Peacock
Journal:  Oncologist       Date:  2015-06-01

3.  Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency.

Authors:  Timothy P Hanna; Alfred C T Kangolle
Journal:  BMC Int Health Hum Rights       Date:  2010-10-13

4.  International comparison of the factors influencing reimbursement of targeted anti-cancer drugs.

Authors:  Carol Sunghye Lim; Yun-Gyoo Lee; Youngil Koh; Dae Seog Heo
Journal:  BMC Health Serv Res       Date:  2014-11-29       Impact factor: 2.655

5.  Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care.

Authors:  Dan Greenberg; Ariel Hammerman; Shlomo Vinker; Adi Shani; Yuval Yermiahu; Peter J Neumann
Journal:  Isr J Health Policy Res       Date:  2013-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.